Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study

✍ Scribed by Kavanaugh, Arthur (author);Fleischmann, Roy M. (author);Emery, Paul (author);Kupper, Hartmut (author);Redden, Laura (author);Guerette, Benoit (author);Santra, Sourav (author);Smolen, Josef S. (author)

• Book ID: 126635605
• Publisher: BMJ Publishing Group
• Year: 2012
• Tongue: English
• Weight: 892 KB
• Volume: 72
• Category: Article
• ISSN: 0003-4967
• DOI: 10.1136/annrheumdis-2011-201247